Clinical Trials Logo

Clinical Trial Summary

Taken recent literature together, there is a sufficient number of trials investigating the effect of different oxygen devices. However, studies comparing oxygen delivery via portable oxygen concentrator (POC) and liquid oxygen device (LOD) with appropriate exercise testing and sufficient power are missing.

Given that walking is the most important activity of daily life to preserve the maintenance and to participate in social life, we aim to investigate the effects of two different oxygen delivery systems during walking in hypoxemic COPD patients (POC vs. LOD).

The endurance shuttle walk test (ESWT) is well validated for measuring endurance walking capacity in COPD patients with good repeatability. The advantage of this test over the 6MWT is that the ESWT is performed at 85% of the individual maximum which is close to the intensity of typical daily activities. Due to the fact that the ESWT enables us to determine the maximum duration of exercise and to compare values at isotime (at the point of time when the shortest of the 3 ESWTs ends), we use the ESWT as exercise test in our trial.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02998515
Study type Interventional
Source Klinikum Berchtesgadener Land der Schön-Kliniken
Status Completed
Phase N/A
Start date December 2016
Completion date March 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03923660 - Ventilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD N/A
Not yet recruiting NCT04018729 - Cell Therapy Associated With Endobronchial Valve Phase 2/Phase 3
Recruiting NCT04848012 - Efficacy of an Advanced Auto-titrating NIV in COPD N/A
Recruiting NCT03398772 - Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease. N/A
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Recruiting NCT04069312 - Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Phase 3
Completed NCT04533516 - Additional Manual Therapy Over Inspiratory Muscle Training in COPD N/A